Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GSK-3α inhibitors(glycogen synthase kinase 3 alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | FR | 04 Mar 2023 | |
Glioblastoma | Preclinical | TN | 04 Mar 2023 |